Notably, TLR3 activation promotes high expression of IL-13 in type 2 innate lymphoid cells (ILC2) and alveolar macrophages, leading to airway hyperresponsiveness and increased mucus production (174). The gene discussed is TLR3; the disease is airway hyperresponsiveness.